ARCHIVES

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

This article is from The Cancer Letter archive.

Vol. 13 No. 48 | December 11, 1987

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Recompetition Of Two Major Contracts

October 30, 1987

Colorado Institutions Vying to Build First Carbon Ion Center in the U.S.

September 26, 2014

Study Finds That CTC Was Used Correctly In Medicare Patients

April 26, 2013

DCT Board Approves Drug Development Recompetition

November 30, 1990

Triple Combination Chemotherapy Effective For Advanced Colorectal Cancer, Trial Finds

January 27, 2006

European Treatment Regimen Less Toxic Than American Method

April 26, 2013